Cargando…
Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects
Resistance to antimicrobial agents has been alarming in recent years and poses a huge public health threat globally according to the WHO. The increase in morbidity and mortality resulting from microbial infections has been attributed to the emergence of multidrug-resistant microbes. Associated with...
Autores principales: | Mba, Ifeanyi E., Nweze, Emeka I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159659/ https://www.ncbi.nlm.nih.gov/pubmed/34046779 http://dx.doi.org/10.1007/s11274-021-03070-x |
Ejemplares similares
-
Antimicrobial Peptides Therapy: An Emerging Alternative for Treating
Drug-Resistant Bacteria
por: Mba, Ifeanyi Elibe, et al.
Publicado: (2022) -
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival
por: Mba, Ifeanyi, et al.
Publicado: (2022) -
Therapeutic Options and Outcomes for the Treatment of Neonates and Preterms with Gram-Negative Multidrug-Resistant Bacteria: A Systematic Review
por: Chiusaroli, Lorenzo, et al.
Publicado: (2022) -
Research Progress and Prospects of Autophagy in the Mechanism of Multidrug Resistance in Tumors
por: Long, Wenqing, et al.
Publicado: (2022) -
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
por: Furin, Jennifer, et al.
Publicado: (2016)